StockDriftsStockDriftsTop 31 Squadron Capital Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | 17.41% | 7.35M | $50.9M | -13.27%(-1.12M) | $3.94(+21.88%) | 2026-06-30 | |
| CCCC | C4 THERAPEUTICS INC | 11.51% | 7.20M | $33.6M | +220.00%(+4.95M) | $3.12(+35.79%) | 2026-06-30 | |
| COGT | COGENT BIOSCIENCES INC | 11.46% | 865.0K | $33.5M | +9.84%(+77.51K) | $26.13(+45.16%) | 2026-06-30 | |
| KOD | KODIAK SCIENCES INC | 6.67% | 500.0K | $19.5M | +31.58%(+120.00K) | $27.48(+50.47%) | 2026-06-30 | |
| RLAY | RELAY THERAPEUTICS INC | 6.21% | 970.0K | $18.1M | +44.24%(+297.50K) | $10.68(+85.87%) | 2026-06-30 | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 6.14% | 3.70M | $17.9M | +1.90%(+69.00K) | $1.88(+89.79%) | 2026-06-30 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 4.03% | 290.0K | $11.8M | -17.14%(-60.00K) | $20.52(+115.28%) | 2026-06-30 | |
| MAZE | MAZE THERAPEUTICS INC | 3.42% | 335.0K | $10.0M | +30.10%(+77.50K) | $32.70(-16.87%) | 2026-06-30 | |
| IVA | INVENTIVA SA | 3.15% | 2.44M | $9.2M | +355.14%(+1.90M) | $4.75(-3.12%) | 2026-06-30 | |
| ANL | ADLAI NORTYE LTD | 3.01% | 764.9K | $8.8M | -39.55%(-500.36K) | $4.17(+217.75%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (2 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +26.55% |
| Top 20 Holdings Unweighted | — | — | — | — | +27.10% |
Squadron Capital Management LLC reports $322.25M in US-listed equity holdings across 34 positions in its most recent 13F filing. Its largest disclosed positions are RLMD (17.4%), CCCC (11.5%) and COGT (11.5%). The top 20 holdings account for 90.87% of reported assets. Its disclosed equity book has returned +26.55% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Squadron Capital Management LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Squadron Capital Management LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2050709). View Squadron Capital Management LLC’s 13F filings on SEC